From Pathogens to Therapeutics: Harnessing Parasite Nanomaterials in Precision Oncology
WIREs Nanomedicine and Nanobiotechnology · 2026-11 · 18 (6)
DOI: 10.1002/wnan.70084 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, online erschienen am 02.11.2026. Verfasst von Chenhao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Engineering Research Center of Molecular Theranostic Technology, School of Public Health, Xiamen University, Xiamen, Fujian, China. Hauptthemen laut MEDLINE: Nanostructures, Neoplasms, Precision Medicine, Parasites. Die Arbeit nennt 123 Literaturangaben. Gefördert von: Shenzhen Medical Research Fund, National Natural Science Foundation of China, Science, Technology and Innovation Commission of Shenzhen Municipality.
Abstract (Originalsprache)
Parasites are one of the pathogens' threats to human and animal health, yet emerging evidence reveals their paradoxical potential as valuable therapeutic agents in oncology. Parasitic derivatives demonstrate remarkable tumor specificity, selectively eliminating malignant cells while sparing normal tissues. This review systematically summarizes the antitumor mechanisms and applications of major protozoan and helminth parasites investigated to date. The reviewed evidence is derived from in vitro cell‐based assays and syngeneic mouse tumor models. Key mechanisms encompass immunomodulation of host immunity to generate an antitumor microenvironment, selective suppression of tumor angiogenesis, and molecular mimicry that triggers targeted apoptosis in cancer cells. We examine the scientific rationale for developing parasite‐based biologics as a novel class of anticancer therapeutics, highlight their unique advantages and biosafety concerns relative to conventional treatment modalities, and discuss recent efforts to integrate them with nanotechnology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fujian Engineering Research Center of Molecular Theranostic Technology, School of Public Health, Xiamen University, Xiamen, Fujian, China.
- Research Center for High Altitude Medicine, Key Laboratory for High Altitude Medicine (Ministry of Education), Laboratory for High Altitude Medicine of Qinghai Province, Qinghai University, Xining, China.
- Department of Nuclear Medicine, School of Public Health, the Second Affiliated Hospital of Chengdu Medical College, China National Nuclear Corporation 416 Hospital, Chengdu, China.
- State Key Laboratory of Stress Biology and Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.
- Department of Basic Medicine, Key Laboratory of Functional and Clinical Translational Medicine, Xiamen Medical College, Xiamen, China.
- Shenzhen Research Institute of Xiamen University, Shenzhen, China.
ORCID-Profile: Xiaoyu An, Qianwen Mu, Chao Liu, Gang Liu
Förderung
- Shenzhen Medical Research Fund
- National Natural Science Foundation of China
- Science, Technology and Innovation Commission of Shenzhen Municipality
- Basic and Applied Basic Research Foundation of Guangdong Province
- Natural Science Foundation of Fujian Province
- China Postdoctoral Science Foundation
- Open Project of Key Laboratory of High Altitude Medicine (Ministry of Education)
- Xiamen Medical Research Fund
Zitieren
APA
Zhang, C., Huang, Q., An, X., Mu, Q., Liu, H., Wu, Y., Liu, C., & Liu, G. (2026). From Pathogens to Therapeutics: Harnessing Parasite Nanomaterials in Precision Oncology. WIREs Nanomedicine and Nanobiotechnology, 18(6). https://doi.org/10.1002/wnan.70084
Vancouver
Zhang C, Huang Q, An X, Mu Q, Liu H, Wu Y, et al. From Pathogens to Therapeutics: Harnessing Parasite Nanomaterials in Precision Oncology. WIREs Nanomedicine and Nanobiotechnology. 2026;18(6). doi:10.1002/wnan.70084
BibTeX
@article{Zhang2026,
author = {Zhang, Chenhao and Huang, Qihang and An, Xiaoyu and Mu, Qianwen and Liu, Huanhuan and Wu, Yaming and Liu, Chao and Liu, Gang},
title = {From Pathogens to Therapeutics: Harnessing Parasite Nanomaterials in Precision Oncology},
journal = {WIREs Nanomedicine and Nanobiotechnology},
year = {2026},
volume = {18},
number = {6},
doi = {10.1002/wnan.70084}
}
EUVIMED